Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lance Leopold, MD
Ascenta Therapeutics, Inc.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Center (16)
Russia, Russia, Russia
- Research Centers (8)
Ukraine, Ukraine, Ukraine
- Facility name not stated
Birmingham, Alabama, United States
- Facility name not stated
Hot Springs, Arkansas, United States
- Facility name not stated
Loma Linda, California, United States
- Facility name not stated
Stamford, Connecticut, United States
- Facility name not stated
Jacksonville, Florida, United States
- Facility name not stated
Lake City, Florida, United States
- Facility name not stated
Boston, Massachusetts, United States
- Facility name not stated
Rochester, Minnesota, United States
- Facility name not stated
Lebanon, New Hampshire, United States
- Facility name not stated
High Point, North Carolina, United States
- Facility name not stated
Portland, Oregon, United States
- Facility name not stated
Columbia, South Carolina, United States
- Facility name not stated
Hilton Head Island, South Carolina, United States
- Facility name not stated
Germantown, Tennessee, United States
- Facility name not stated
Austin, Texas, United States
- Facility name not stated
Burlington, Vermont, United States
- Facility name not stated
Huntington, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2006
- Primary completion
- 31 Dec 2008
- Completion
- 31 Dec 2008
- Last update posted
- 24 Aug 2010
- Registered enrollment
- 36
- Registry id
- NCT00397293
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.